Global Biologics Contract Development Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Source;
Microbial, Mammalian and Others.Segmented by Product;
Cell Line Development - Microbial, Mammalian and Others, Process Development - Upstream[Microbial, Mammalian and Others], - Downstream[Impurity, isolation, & identification, Physicochemical characterization, Pharmaceutical analysis and Others], - By Product[MABs, Recombinant proteins and Others].Segmented by Indication;
Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders and Others.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Biologics Contract Development Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 80.4 |
2021 | 91.6 |
2022 | 92.7 |
2023 | 95.7 |
2024 | 103.1 |
2025 | 106.0 |
2026 | 121.0 |
2027 | 124.2 |
2028 | 125.1 |
2029 | 133.3 |
2030 | 153.5 |
In the year 2023, the Global Biologics Contract Development Market was valued at USD 7,847.00 million. The size of this market is expected to increase to USD 14,161.39 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 8.8%.
Global Biologics Contract Development Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Biologics Contract Development Market |
Study Period | 2020 - 2030 |
Base Year (for Biologics Contract Development Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Biologics Contract Development Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Biologics Contract Development Market Analysis
In this report, the Global Biologics Contract Development Market has been segmented by Source, Product, Indication and Geography.
Global Biologics Contract Development Market, Segmentation by Source
The Global Biologics Contract Development Market has been segmented by Source into Microbial, Mammalian and Others. The complete Global Biologics Contract Development Market segmentation by Source can be seen below:
- Global Biologics Contract Development Market, By Source
- Microbial
- Mammalian
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Sources mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Source is increasing or decreasing with time along with the reasons for changes in the YOY growth with time. Based on the source, the contract development process is segmented into api manufacturing, finished product manufacturing, solid dosage forms, injectables, discovery, preclinical, clinical, laboratory services, packaging, and others.
Global Biologics Contract Development Market, by Source (USD Million), 2020 - 2030
# | Microbial | Mammalian | Others |
---|---|---|---|
2020 | 87.0 | 78.6 | 61.1 |
2021 | 93.7 | 90.0 | 72.0 |
2022 | 94.8 | 92.8 | 80.7 |
2023 | 107.3 | 103.0 | 89.7 |
2024 | 121.6 | 117.2 | 100.0 |
2025 | 128.8 | 130.3 | 102.3 |
2026 | 134.1 | 140.7 | 115.7 |
2027 | 153.6 | 151.0 | 130.1 |
2028 | 175.0 | 164.8 | 151.3 |
2029 | 200.0 | 171.1 | 172.2 |
2030 | 232.2 | 180.6 | 202.0 |
Global Biologics Contract Development Market, Segmentation by Product
The Global Biologics Contract Development Market has been segmented by Product into Cell Line Development, Process Development and Others. The complete Global Biologics Contract Development Market segmentation by Product can be seen below:
- Global Biologics Contract Development Market, By Product
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Products mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Product is increasing or decreasing with time along with the reasons for changes in the YOY growth with time. Self service technologies market by product is segmented into conventional atm, white label atm, brown label atm, smart atm, cash dispenser, photo kiosk, ticketing kiosk, hr and employment kiosk, information providing kiosk, beverage vending machine, candy vending machine, snack vending machine, gumball vending machine and cigarette vending machine. Electronic shelf label market by product type is divided into lcd, segmented e-paper, and full-graphic e-paper. Data quality tools market on the basis of product is segmented into financial data, supplier data, customer data, and healthcare and life sciences. On the basis of product, the auto accessories market is segmented into external component (racks, led lights, body kits, chrome accessories, covers, alloy wheels, window films, helmets, covers, electronics accessories, knobs, communication system, mats, fragrance, central locking system, dash kits, and others. The remote asset management market is segmented by product fixed asset, mobile asset. Functional flour market is segmented by product is specialty flour & conventional flour.
Global Biologics Contract Development Market, by Product (USD Million), 2020 - 2030
# | Cell Line Development | Process Development | Others |
---|---|---|---|
2020 | 57.4 | 67.0 | 53.8 |
2021 | 61.8 | 77.2 | 57.7 |
2022 | 62.8 | 84.0 | 68.3 |
2023 | 67.4 | 93.7 | 72.5 |
2024 | 78.5 | 105.5 | 72.7 |
2025 | 89.6 | 115.5 | 79.9 |
2026 | 100.8 | 123.8 | 92.0 |
2027 | 115.4 | 143.2 | 109.6 |
2028 | 136.0 | 162.2 | 120.6 |
2029 | 141.7 | 181.6 | 135.0 |
2030 | 161.3 | 193.9 | 147.4 |
Global Biologics Contract Development Market, Segmentation by Indication
The Global Biologics Contract Development Market has been segmented by Indication into Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders and Others. The complete Global Biologics Contract Development Market segmentation by Indication can be seen below:
- Global Biologics Contract Development Market, By Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Indications mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Indication is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Biologics Contract Development Market, by Indication (USD Million), 2020 - 2030
# | Oncology | Immunological disorders | Cardiovascular disorders | Hematological disorders | Others |
---|---|---|---|---|---|
2020 | 83.9 | 67.9 | 72.4 | 93.5 | 72.2 |
2021 | 99.8 | 74.3 | 76.5 | 94.7 | 85.0 |
2022 | 106.0 | 76.6 | 89.0 | 105.6 | 97.7 |
2023 | 107.7 | 85.0 | 98.4 | 126.0 | 97.7 |
2024 | 111.4 | 89.9 | 110.2 | 145.2 | 101.9 |
2025 | 111.7 | 105.8 | 114.0 | 169.4 | 120.0 |
2026 | 127.7 | 117.6 | 128.5 | 201.0 | 131.2 |
2027 | 151.6 | 139.1 | 136.3 | 232.7 | 151.9 |
2028 | 179.8 | 157.6 | 161.0 | 237.0 | 157.5 |
2029 | 189.2 | 166.4 | 189.1 | 242.3 | 168.8 |
2030 | 198.2 | 173.5 | 200.3 | 266.5 | 194.4 |
Global Biologics Contract Development Market, Segmentation by Geography
In this report, the Global Biologics Contract Development Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The zion global services are spread across north america, europe, asia pacific, uae, dubai, saudi arabia, singapore, and others.
Global Biologics Contract Development Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Biologics Contract Development Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Biologics Contract Development in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Biologics Contract Development Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The factors driving the growth of Global Biologics Contract Development Market will be discussed in detail in the full report.
- The factors hindering the growth of Global Biologics Contract Development Market will be discussed in detail in the full report.
- The new opportunities in Global Biologics Contract Development Market will be discussed in detail in the full report.
- Global Biologics Contract Development Market Drivers will be discussed in detail in the full report.
- Global Biologics Contract Development Market Restraints will be discussed in detail in the full report.
- Global Biologics Contract Development Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Biologics Contract Development Market. The opportunity map (by market segments; Source, Product and Indication) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Biologics Contract Development Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Biologics Contract Development Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Biologics Contract Development Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Biologics Contract Development Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.Advanced environmental recycling technologies inc., azek building products inc., cardinal building products, certainteed corporation, duralife decking and railing systems, fiberon llc, green bay decking, tamco building products inc., and upm kymmene corporation are among the top market players in the plastic decking market. In addition, Universal Forest Products Inc. The lighting as a service market is dominated by companies such as Koninklijke Philips, abb (cooper industries), General Electric, osram, sib lighting, Cree, and others. Intel Corporation, Dasault Systemes, Autodesk, Adobe Systems, Advanced Micro Devices (AMD), Mentor Graphics, Sony, Siemens Plm Software, Nvidia, and Microsoft are some of the key players in the computer graphics market. Siemens ag, abb ltd., eaton corporation plc, larsen & toubro limited, and schneider electric se are some of the key players in the distribution boards market.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Biologics Contract Development Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Biologics Contract Development Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Biologics Contract Development Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Biologics Contract Development Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Biologics Contract Development Market include, Wuxi Biologics, Abzena Ltd., FUJIFILM Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Lakepharma, Inc., Genscript and BioNova Scientific.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Source
- Market Snapshot, By Product
- Market Snapshot, By Indication
- Market Snapshot, By Region
- Market Opportunity Map
- Global Biologics Contract Development Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Restraints
- Opportunities
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Biologics Contract Development Market, By Source, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Microbial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Microbial
- Global Biologics Contract Development Market, By Product, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Cell Line Development
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Microbial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Microbial
- Process Development
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Upstream
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Microbial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Microbial
- Downstream
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Impurity, isolation, & identification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Physicochemical characterization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Pharmaceutical analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Impurity, isolation, & identification
- By Product
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- MABs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Recombinant proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- MABs
- Upstream
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Cell Line Development
- Global Biologics Contract Development Market, By Indication, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Immunological disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Cardiovascular disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Hematological disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Oncology
- Global Biologics Contract Development Market, By Geography, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
- GCC
- North America
- Global Biologics Contract Development Market, By Source, 2022 - 2032 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Wuxi Biologics
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Abzena Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- FUJIFILM Diosynth Biotechnologies
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- KBI Biopharma
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- AGC Biologics
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Lakepharma, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Genscript
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- BioNova Scientific
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Wuxi Biologics
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Biopharmaceutical CMO & CRO Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Biopharmaceutical Excipients Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Biopharmaceutical Third Party Logistics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Bioprosthetics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%